The Novo Nordisk Foundation has allocated up to 736m euros in funding to BioInnovation Institute (BII), a leading institute ...

Novo Nordisk has found a buyer for cell therapy technologies dropped in its retreat from the modality. Aspect Biosystems has ...

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe ...

Jan 20 (Reuters) - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have ...

Aspect will acquire rights from Novo Nordisk to stem cell-derived islet cell and hypoimmune cell engineering technologies.

The Novo Nordisk Foundation is investing 5.5 billion Danish kroner ($860 million) in the BioInnovation Institute (BII) to help scale up more homegrown biotechs and deep tech companies. | The Novo ...

Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect BiosystemsAspect will ...

Why economic leverage beats military pressure on Greenland, and how Denmark’s exposure through Novo Nordisk makes trade tools ...

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an "encouraging" ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Shares in Denmark's global healthcare company, Novo Nordisk jumped sharply on Friday after the U.K.'s regulator signed off on ...